Response Adaptive Radiotherapy Following Immunotherapy-based Induction for Non-HPV Related HNSCC

Clinical trial NCT06345287 · RECRUITING

Trial details

NCT number: NCT06345287
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Cancer

Start date: 2024-01-01
Primary completion: 2025-12-31
Enrollment: 133

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.